Michihiro Uchiyama

Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a randomised, multicentre, open-label, phase 3 study

Michel Attal, Paul G. Richardson, S. Vincent Rajkumar et al. · The Lancet · 2019 · 620 citations

Hematological Malignancy, Medicine, Immunology +6

Isatuximab, carfilzomib, and dexamethasone in relapsed multiple myeloma (IKEMA): a multicentre, open-label, randomised phase 3 trial

Philippe Moreau, Meletios Α. Dimopoulos, Joseph Mıkhael et al. · The Lancet · 2021 · 366 citations

Hematological Malignancy, Relapsed Multiple Myeloma, Medicine +11

Comparative single-institute analysis of cord blood transplantation from unrelated donors with bone marrow or peripheral blood stem-cell transplants from related donors in adult patients with hematologic malignancies after myeloablative conditioning regimen

Satoshi Takahashi, Jun Ooi, Akira Tomonari et al. · Blood · 2006 · 298 citations · Full text

Oral Iptacopan Monotherapy in Paroxysmal Nocturnal Hemoglobinuria

Régis Peffault de Latour, Alexander Röth, Austin Kulasekararaj et al. · New England Journal of Medicine · 2024 · 119 citations · Full text

Treatment of Alzheimer-type dementia with intravenous mecobalamin.

Takuo Ikeda, Kodai Yamamoto, K. Takahashi et al. · PubMed · 1992 · 28 citations